Literature DB >> 3029488

Active inflammatory change of the liver as a cause of postoperative hepatic failure.

M Sakurai, J Okamura, C Kuroda, T Yamada.   

Abstract

Histopathology of cirrhosis was compared to the hepatic functional reserve and to the prognosis. One hundred and thirteen patients including 51 surgically treated for hepatocellular carcinoma (HCC) and 62 subjected to wedge biopsy of the liver during surgery for esophageal varices were studied. The type of cirrhosis associated with hepatocellular carcinoma was classified into 4 groups according to the degree of inflammation and the piecemeal necrosis. Of the 16 without cirrhosis, 13 (81 per cent) are living. Nine had an inactive cirrhosis and 5 (56 per cent) are living. Ten had a slightly active cirrhosis and 4 (40 per cent) are living. Sixteen had a fairly active cirrhosis and 7 (44 per cent) are alive. Immediate postoperative death due to acute hepatic failure occurred in 6, 4 of whom had a fairly active cirrhosis. In patients with active alcoholic hepatitis with numerous Mallory bodies and ballooning degeneration of liver cells, the prognosis was the poorest, if the liver was resected, even though the functional reserve seemed to be adequate. To prevent acute hepatic failure, liver histology during the surgery is predictive and wedge biopsy of the liver is recommended.

Entities:  

Mesh:

Year:  1986        PMID: 3029488     DOI: 10.1007/BF02470606

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  7 in total

1.  Posthepatitic, postnecrotic, and nutritional cirrhosis: a pathologic analysis.

Authors:  E A GALL
Journal:  Am J Pathol       Date:  1960-03       Impact factor: 4.307

2.  Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati.

Authors:  W Mori
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

3.  An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies.

Authors:  J Okamura; S Horikawa; T Fujiyama; M Monden; J Kambayashi; O Sikujara; M Sakurai; C Kuroda; H Nakamura; G Kosaki
Journal:  World J Surg       Date:  1982-05       Impact factor: 3.352

4.  Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study.

Authors:  M Sakurai; J Okamura; C Kuroda
Journal:  Cancer       Date:  1984-08-01       Impact factor: 6.860

5.  Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function.

Authors:  E Okamoto; A Kyo; N Yamanaka; N Tanaka; K Kuwata
Journal:  Surgery       Date:  1984-05       Impact factor: 3.982

6.  Primary liver cancer in Japan. The Liver Cancer Study Group of Japan.

Authors: 
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860

7.  Estimation of the functional reserve of human liver.

Authors:  F G Moody; L F Rikkers; J S Aldrete
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

  7 in total
  3 in total

1.  Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented?

Authors:  K Takenaka; T Kanematsu; K Fukuzawa; K Sugimachi
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

2.  Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure.

Authors:  H Eguchi; K Umeshita; M Sakon; H Nagano; Y Ito; S I Kishimoto; K Dono; S Nakamori; T Takeda; M Gotoh; K Wakasa; N Matsuura; M Monden
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

3.  Follow-up study of combination treatment (TAE and PEIT) for unresectable hepatocellular carcinoma.

Authors:  H Tateishi; M Kinuta; J Furukawa; N Takata; H Maruyama; H Oi; E Yayoi; J Okamura
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.